204 related articles for article (PubMed ID: 22388630)
61. Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy.
van Hagen PM; Breeman WA; Bernard HF; Schaar M; Mooij CM; Srinivasan A; Schmidt MA; Krenning EP; de Jong M
Int J Cancer; 2000 Aug; 90(4):186-98. PubMed ID: 10993959
[TBL] [Abstract][Full Text] [Related]
62. Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors.
Zhang H; Chen J; Waldherr C; Hinni K; Waser B; Reubi JC; Maecke HR
Cancer Res; 2004 Sep; 64(18):6707-15. PubMed ID: 15374988
[TBL] [Abstract][Full Text] [Related]
63. Gastrin-releasing peptide (GRP) analogues for cancer imaging.
Varvarigou A; Bouziotis P; Zikos C; Scopinaro F; De Vincentis G
Cancer Biother Radiopharm; 2004 Apr; 19(2):219-29. PubMed ID: 15186603
[TBL] [Abstract][Full Text] [Related]
64. Peptide-mediated delivery of therapeutic and imaging agents into mammalian cells.
Stefanidakis M; Koivunen E
Curr Pharm Des; 2004; 10(24):3033-44. PubMed ID: 15379666
[TBL] [Abstract][Full Text] [Related]
65. 18F-labeled bombesin analog for specific and effective targeting of prostate tumors expressing gastrin-releasing peptide receptors.
Honer M; Mu L; Stellfeld T; Graham K; Martic M; Fischer CR; Lehmann L; Schubiger PA; Ametamey SM; Dinkelborg L; Srinivasan A; Borkowski S
J Nucl Med; 2011 Feb; 52(2):270-8. PubMed ID: 21233180
[TBL] [Abstract][Full Text] [Related]
66. Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: species and gender differences.
Melis M; Krenning EP; Bernard BF; de Visser M; Rolleman E; de Jong M
Nucl Med Biol; 2007 Aug; 34(6):633-41. PubMed ID: 17707803
[TBL] [Abstract][Full Text] [Related]
67. Scintigraphic detection of infection and inflammation: new developments with special emphasis on receptor interaction.
van der Laken CJ; Boerman OC; Oyen WJ; van de Ven MT; van der Meer JW; Corstens FH
Eur J Nucl Med; 1998 May; 25(5):535-46. PubMed ID: 9575251
[TBL] [Abstract][Full Text] [Related]
68. 99mTc-labeled vasoactive intestinal peptide analog for rapid localization of tumors in humans.
Thakur ML; Marcus CS; Saeed S; Pallela V; Minami C; Diggles L; Le Pham H; Ahdoot R; Kalinowski EA
J Nucl Med; 2000 Jan; 41(1):107-10. PubMed ID: 10647612
[TBL] [Abstract][Full Text] [Related]
69. Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours.
Abiraj K; Mansi R; Tamma ML; Forrer F; Cescato R; Reubi JC; Akyel KG; Maecke HR
Chemistry; 2010 Feb; 16(7):2115-24. PubMed ID: 20066690
[TBL] [Abstract][Full Text] [Related]
70. Future diagnostic agents.
Gemmel F; Dumarey N; Welling M
Semin Nucl Med; 2009 Jan; 39(1):11-26. PubMed ID: 19038597
[TBL] [Abstract][Full Text] [Related]
71. 99mTc-antimicrobial peptides: promising candidates for infection imaging.
Lupetti A; Pauwels EK; Nibbering PH; Welling MM
Q J Nucl Med; 2003 Dec; 47(4):238-45. PubMed ID: 14973416
[TBL] [Abstract][Full Text] [Related]
72. Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals.
Boerman OC; Oyen WJ; Corstens FH
Semin Nucl Med; 2000 Jul; 30(3):195-208. PubMed ID: 10928383
[TBL] [Abstract][Full Text] [Related]
73. Peptide targeted imaging of cancer.
Riccabona G; Decristoforo C
Cancer Biother Radiopharm; 2003 Oct; 18(5):675-87. PubMed ID: 14629817
[TBL] [Abstract][Full Text] [Related]
74. Peptide receptors in neuroendocrine tumors of the lung as potential tools for radionuclide diagnosis and therapy.
Pelosi G; Volante M; Papotti M; Sonzogni A; Masullo M; Viale G
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):272-87. PubMed ID: 17043625
[TBL] [Abstract][Full Text] [Related]
75. Peptide receptor imaging and therapy.
Kwekkeboom D; Krenning EP; de Jong M
J Nucl Med; 2000 Oct; 41(10):1704-13. PubMed ID: 11038002
[TBL] [Abstract][Full Text] [Related]
76. Imaging infection/inflammation in the new millennium.
Rennen HJ; Boerman OC; Oyen WJ; Corstens FH
Eur J Nucl Med; 2001 Feb; 28(2):241-52. PubMed ID: 11303896
[TBL] [Abstract][Full Text] [Related]
77. Radiolabelled antimicrobial peptides for imaging of infections: a review.
Nibbering PH; Welling MM; van den Broek PJ; van Wyngaarden KE; Pauwels EK; Calame W
Nucl Med Commun; 1998 Dec; 19(12):1117-21. PubMed ID: 9885800
[TBL] [Abstract][Full Text] [Related]
78. Radiopharmaceuticals: new antimicrobial agents.
Lupetti A; Nibbering PH; Welling MM; Pauwels EK
Trends Biotechnol; 2003 Feb; 21(2):70-3. PubMed ID: 12573855
[TBL] [Abstract][Full Text] [Related]
79. Radiolabelled peptides and monoclonal antibodies for therapy decision making in inflammatory diseases.
Malviya G; Signore A; Laganà B; Dierckx RA
Curr Pharm Des; 2008; 14(24):2401-14. PubMed ID: 18781990
[TBL] [Abstract][Full Text] [Related]
80. Influence of labelling methods on biodistribution and imaging properties of radiolabelled peptides for visualisation of molecular therapeutic targets.
Tolmachev V; Orlova A
Curr Med Chem; 2010; 17(24):2636-55. PubMed ID: 20491631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
